8:30am ET
Health and Healthcare
Big Biotechs Scare Off Short Sellers
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Companies
/Healthcare
Biogen Inc
$218.50
▼ $3.00 (−1.35%) today
Markets closed · 8:46am ET
BIIB Coverage
Page 119:05am ET
Health and Healthcare
Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial
Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will be buying back a sizable amount of stock.
Chris Lange 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Best Buy, Biogen, Booking, China Mobile, Chipotle, CNOOC, Kinder Morgan, Lumentum, MongoDB, Nike and More
The top analyst upgrades, downgrades and initiations seen on Friday included Best Buy, Biogen, China Mobile, Chipotle Mexican Grill, CNOOC, Conagra Brands, Kinder Morgan, Lumentum, Nike and Toll Brothers.
4:24pm ET
Health and Healthcare
Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?
Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer’s disease after shares of Biogen Inc. (NASDAQ: BIIB | BIIB Price Prediction) suffered handily with the announcement…
Jon C. Ogg 4:08pm ET
Investing
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a very positive day for the broad U.S. markets. The S&P 500 and DJIA pushed higher in the session largely driven by the tech sector, although the major banks offered…
9:55am ET
Health and Healthcare
Why This Alzheimer’s Study Is Crushing Biogen Shares
Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for Alzheimer’s disease.
Chris Lange 9:05am ET
Health and Healthcare
Major Biotechs See a Rising Tide in Short Interest
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
8:30am ET
Health and Healthcare
Are Nightstar Shareholders Getting Enough in the Buyout?
Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The transaction is expected to close by mid-year 2019.
Chris Lange 8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in most…
8:52am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and Zillow.
8:00am ET
Health and Healthcare
Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Agilent, American Water, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS, Walmart and More
The top analyst upgrades, downgrades and initiations seen on Thursday included Agilent Technologies, American Water Works, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS and Walmart.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Activision, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, GM, Lattice Semi, Qualys, Shopify, Under Armour and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Activision Blizzard, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, General Motors, Lattice Semiconductor, Qualys, Shopify and Under Armour.
9:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in most…
3:01pm ET
Health and Healthcare
Reality Check: Big Biotech and Big Pharma Are Becoming Identical
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,…